Geriatrics
2024 Activity indicators
- 1 competitive European project: So-NUTS (JPI- HDHL)
- 1 private project led
- 4 clinical studies led
- 26 publications
- IF: 163.34
- Q1 publications: 8 (31%)
- D1 publications: 4 (15%)
- Project evaluators: 1 PI
- Members of editorial committees: 5 researchers
- 1 consensus document
- 1 clinical guideline
- 1 visitor and 8 months stay:
- University of Salamanca
Milestones
- Spanish Society of Geriatrics and Gerontology Award for the best original article published in the Revista Española de Geriatría the previous year: "Spanish version of the STOPP/START 3 criteria. Advances in the detection of inappropriate medication prescription in older adults."
- Group leadership in the publication of the first global consensus definition of sarcopenia (GLIS): Kirk B, Cawthon PM, Arai H, Ávila JA, Barazzoni R, Bhasin S, Binder EF, Bruyere O, Cederholm T, Chen LK, Cooper C, Duque G, Fielding RA, Guralnik J, Kiel DP, Landi F, Reginster JY, Sayer AA, Visser M, von S, Woo J, Cruz AJ, Global Leadership Initiative in Sarcopenia (GLIS). The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS). Age Ageing. 2024;53(3): afae052. DOI:10.1093/ageing/afae052.
- Collaboration and visit by University of Salamanca staff in sarcopenia research.
- Completion of the European project SO-NUTs-PCI2020-120683-2, "Preventing sacropenia, obesity, and sarcopenic obesity in retired people," through the development of a personalized digital intervention that optimizes nutritional and physical activity behavior in retirement. This project, with numerous publications and several in progress, has been published.
- Start of collaboration with the "Multisystem Diseases" group on the joint project "Malnutrition and Frailty in Older Patients with HF Treated with GLT2-Is."
Bibliometrics
Articles | Accum. IF | Mean IF | Articles Q1 or Q2 | % in Q1 or Q2 | Articles D1 | % in D1 | |
---|---|---|---|---|---|---|---|
2020 | 26 | 87.94 | 3.38 | 15 | 58 | 3 | 12 |
2021 | 29 | 114.84 | 3.96 | 14 | 48 | 2 | 7 |
2022 | 43 | 408.882 | 9.51 | 18 | 42 | 6 | 14 |
2023 | 26 | 128.30 | 4.93 | 14 | 54 | 5 | 19 |
2024 | 26 | 163.34 | 6.81 | 21 | 81 | 4 | 15 |
150 | 903.30 | 5.72 | 82 | 55 | 20 | 13 |
* Only original articles, editorials, guidelines and reviews